NAMS NewAmsterdam Pharma Co N.V.
2026Q1 · CUSIP N62509109 · Sector: Healthcare & Biotech
Fading · Price holds, watch
Holders
167
Δ holders QoQ
-19
Breadth percentile
Top 92%
Whale holders
87
Δ whales
0
Inst. holding value
$3.9B
New positions
24
Closed positions
43
Price momentum (1Q)
—
Put / Call
6/5
Breadth history (34 quarters)
Past Lit Events & Aftermath 4 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 11% | — | — |
| 2024Q4 | Top 17% | — | — |
| 2024Q2 | Top 19% | — | — |
| 2024Q1 | Top 5% | — | — |
Options Sentiment
Put holders
6
QoQ: +2
Call holders
5
QoQ: 0
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-1.78
EPS YoY
—
Revenue (TTM)
$0.0B
Revenue YoY
-52.1%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)